163 related articles for article (PubMed ID: 24456283)
21. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
[TBL] [Abstract][Full Text] [Related]
22. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
Lu S; Hill J; Fillit H
Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
[TBL] [Abstract][Full Text] [Related]
23. Donepezil (Aricept) for Alzheimer's disease.
Med Lett Drugs Ther; 1997 Jun; 39(1002):53-4. PubMed ID: 9187642
[No Abstract] [Full Text] [Related]
24. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
[TBL] [Abstract][Full Text] [Related]
25. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
26. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60].
Vollmar HC; Butzlaff M
Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187
[No Abstract] [Full Text] [Related]
27. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
Harry RD; Zakzanis KK
Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
[TBL] [Abstract][Full Text] [Related]
28. Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern.
Wolff ML
Am J Geriatr Pharmacother; 2012 Jun; 10(3):219-22. PubMed ID: 22445625
[TBL] [Abstract][Full Text] [Related]
29. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J
Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643
[TBL] [Abstract][Full Text] [Related]
30. New acetylcholinesterase inhibitor (donepezil) treatment for Alzheimer's disease in a chronic dialysis patient.
Suwata J; Kamata K; Nishijima T; Yoshikawa T; Sano M
Nephron; 2002 Jun; 91(2):330-2. PubMed ID: 12053074
[TBL] [Abstract][Full Text] [Related]
31. Serum adipokine levels modified by donepezil treatment in Alzheimer's disease.
Pákáski M; Fehér A; Juhász A; Drótos G; Fazekas OC; Kovács J; Janka Z; Kálmán J
J Alzheimers Dis; 2014; 38(2):371-7. PubMed ID: 23979024
[TBL] [Abstract][Full Text] [Related]
32. Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies.
Cummings J; Lai TJ; Hemrungrojn S; Mohandas E; Yun Kim S; Nair G; Dash A
CNS Neurosci Ther; 2016 Mar; 22(3):159-66. PubMed ID: 26778658
[TBL] [Abstract][Full Text] [Related]
33. [The efficacy of donepezil hydrochloride on the Apathy scale in Alzheimer's disease].
Oguro H; Onoda K; Kobayashi S; Yamaguchi S
Nihon Ronen Igakkai Zasshi; 2010; 47(5):481-2. PubMed ID: 21116094
[No Abstract] [Full Text] [Related]
34. Comments on the article by Mazza et al. concerning Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
Korczyn AD
Eur J Neurol; 2007 Sep; 14(9):e9; author reply e10. PubMed ID: 17718684
[No Abstract] [Full Text] [Related]
35. Use of donepezil in elderly patients with Alzheimer's disease--a Hawaii based study.
Alagiakrishnan K; Wong W; Blanchette PL
Hawaii Med J; 2000 Feb; 59(2):57-9. PubMed ID: 10800254
[TBL] [Abstract][Full Text] [Related]
36. A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease.
Burns A; Perry E; Holmes C; Francis P; Morris J; Howes MJ; Chazot P; Lees G; Ballard C
Dement Geriatr Cogn Disord; 2011; 31(2):158-64. PubMed ID: 21335973
[TBL] [Abstract][Full Text] [Related]
37. Donepezil use for advanced Alzheimer's disease--a case study from a long-term care facility.
Tariot PN; Jakimovich L
J Am Med Dir Assoc; 2003; 4(4):216-9. PubMed ID: 12837144
[TBL] [Abstract][Full Text] [Related]
38. A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease.
Wilkinson DG; Passmore AP; Bullock R; Hopker SW; Smith R; Potocnik FC; Maud CM; Engelbrecht I; Hock C; Ieni JR; Bahra RS
Int J Clin Pract; 2002; 56(6):441-6. PubMed ID: 12166542
[TBL] [Abstract][Full Text] [Related]
39. Replication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer's disease patients.
Albani D; Martinelli Boneschi F; Biella G; Giacalone G; Lupoli S; Clerici F; Benussi L; Ghidoni R; Galimberti D; Squitti R; Mariani S; Confaloni A; Bruno G; Mariani C; Scarpini E; Binetti G; Magnani G; Franceschi M; Forloni G
J Alzheimers Dis; 2012; 30(4):745-9. PubMed ID: 22465999
[TBL] [Abstract][Full Text] [Related]
40. A case series of D-cycloserine added to donepezil in the treatment of Alzheimer's disease.
Falk WE; Daly EJ; Tsai GE; Gunther J; Brown P
J Neuropsychiatry Clin Neurosci; 2002; 14(4):466-7. PubMed ID: 12426422
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
